Stay updated on Endovascular Treatment With or Without IV rhTNK-tPA Clinical Trial
Sign up to get notified when there's something new on the Endovascular Treatment With or Without IV rhTNK-tPA Clinical Trial page.

Latest updates to the Endovascular Treatment With or Without IV rhTNK-tPA Clinical Trial page
- Check2 days agoChange DetectedThe page has removed a citation regarding the effect of intravenous Tenecteplase dose on cerebral reperfusion, which is a significant study in the field of ischemic stroke treatment.SummaryDifference0.3%
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed trial information and the addition of new collaborators and investigators. The revision number has also been updated.SummaryDifference20%
- Check31 days agoChange DetectedThe webpage has undergone significant updates to the eligibility criteria for intravenous thrombolysis treatment in patients with acute ischemic stroke, including the addition of specific conditions and exclusions. Additionally, several contact details for study personnel have been removed.SummaryDifference24%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Endovascular Treatment With or Without IV rhTNK-tPA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Endovascular Treatment With or Without IV rhTNK-tPA Clinical Trial page.